Experimental therapeutic investigations with 1-(morpholinomethyl)-4-phthalimido-piperidindione-2,6 on dimethylbenzanthracene-induced tumors of Sprague-Dawley rats.
D000728:Androgens / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001551:Benz(a)Anthracenes; D001835:Body Weight; D002369:Castration; D004958:Estradiol / Q000627:therapeutic use; D004971:Estrus / Q000187:drug effects; D005260:Female; D007016:Hypophysectomy; D008656:Mestranol / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000188:drug therapy* / Q000601:surgery; D010880:Piperidines / Q000627:therapeutic use*; D011247:Pregnancy; D051381:Rats
D000728:Androgens; D000970:Antineoplastic Agents; D001551:Benz(a)Anthracenes; D009025:Morpholines; D010880:Piperidines; D004958:Estradiol; D008656:Mestranol